isocarboxazid has been researched along with Chronic Illness in 3 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davidson, J | 1 |
| Sullivan, JL | 1 |
| Berlanga, C | 1 |
| Ortega-Soto, HA | 1 |
| Zall, H | 1 |
3 other studies available for isocarboxazid and Chronic Illness
| Article | Year |
|---|---|
Relapse, side effects, and monoamine oxidase inhibition during long term use of isocarboxazid: a case report.
Topics: Anxiety; Chronic Disease; Depressive Disorder; Female; Humans; Isocarboxazid; Middle Aged; Monoamine | 1983 |
A 3-year follow-up of a group of treatment-resistant depressed patients with a MAOI/tricyclic combination.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Chronic Disease; Depressiv | 1995 |
Lithium carbonate and isocarboxazid--an effective drug approach in severe depressions.
Topics: Adult; Affect; Carbonates; Chronic Disease; Drug Synergism; Female; Humans; Imipramine; Isocarboxazi | 1971 |